Pinealon vs Glutathione (GSH)
Both Pinealon and Glutathione (GSH) are used for longevity. Here's how their evidence, dosing, and regulatory status actually compare.
Pinealon
Evidence CPinealon (EDR)
A short tripeptide developed in Russia for cognitive aging and oxidative stress. Limited Western clinical evidence.
View full Pinealon profile →Glutathione (GSH)
Evidence BReduced L-Glutathione
Technically a tripeptide (γ-glutamyl-cysteinyl-glycine) and the body's primary antioxidant. Often grouped with peptide therapy in IV/compounded form for liver support and oxidative stress.
View full Glutathione (GSH) profile →Side-by-Side
| Attribute | Pinealon | Glutathione (GSH) |
|---|---|---|
| Evidence Grade | C | B |
| FDA Status | Not FDA-approved — Russian-origin research peptide | Not FDA-approved as therapeutic — sold as supplement; intravenous use compounded |
| Typical Dose | 5–10 mg daily for 10–20 days (subcutaneous, cycled) | 200–600 mg sublingual / 600–2400 mg IV (compounded) |
| Clinics Indexed | 9 | 312 |
| Categories | cognitive, longevity | antioxidant, longevity |
Key reported benefits — Pinealon
- ✓Cognitive function (preclinical)
- ✓Reduced oxidative damage
- ✓Sleep/circadian effects
Key reported benefits — Glutathione (GSH)
- ✓Master antioxidant
- ✓Liver detoxification support
- ✓Oxidative stress reduction
Educational use only
This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.